Abstract
Type II heparin‐induced thrombocytopenia (HIT) is a potentially severe adverse effect of heparin treatment triggered by an immune response. Although most cases occur in patients receiving unfractioned heparin, HIT can also arise after low‐molecular‐weight heparin (LMWH). We report a case of HIT in a postoperative orthopedic 75‐year‐old woman in treatment with LMWH (nadroparin) complicated by pulmonary embolism and treated successfully with recombinant hirudin. Early recognition and proper treatment are fundamental for the management of this life‐threatening disorder. Copyright © 2010 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (259.6 KB).
References
- 1. Fabris F, Luzzatto G, Stefani PM, Girolami B, Cella G, Girolami A. Heparin‐induced thrombocytopenia. Haematologica 2000; 85(1): 72–81. [PubMed] [Google Scholar]
- 2. Warkentin TE, Levine MN, Hirsh J, et al Heparin‐induced thrombocytopenia in patients treated with low‐molecular‐weight heparin or unfractionated heparin. N Engl J Med 1995. 332: 1330–1335. [DOI] [PubMed] [Google Scholar]
- 3. Warkentin TE. Heparin‐induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121(4): 533–535. [DOI] [PubMed] [Google Scholar]
- 4. Warkentin TE. Heparin induced thrombocytopenia. Diagnosis and management. Circulation 2004; 110(18): 454–458. [DOI] [PubMed] [Google Scholar]
- 5. Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin‐induced thrombocytopenia. Blood 2006; 108(9): 2937–2941. [DOI] [PubMed] [Google Scholar]
- 6. Martel N, Lee J, Wells PS. Risk for heparin‐induced thrombocytopenia with unfractionated and low‐molecular‐weight heparin thromboprophylaxis: a meta‐analysis. Blood 2005; 106: 2710–2715. [DOI] [PubMed] [Google Scholar]
- 7. Hirsh J, Heddle N, Kelton JG. Treatment of heparin‐induced thrombocytopenia: a critical review. Arch Intern Med 2004; 164(4): 361–369. [DOI] [PubMed] [Google Scholar]
- 8. Lubenow N, Eichler P, Lietz T, Farner B, Greinacher A. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin‐induced thrombocytopenia: an analysis of three prospective studies. Blood 2004; 104: 3072–3077. [DOI] [PubMed] [Google Scholar]
- 9. Greinacher A, Janssens U, Berg G, et al. Lepirudin (recumbinant hirudin) for parenteral anticoagulation in patients with heparin‐induced thrombocytopenia. Heparin‐Associated Thrombocytopenia Study (HAT) investigators. Circulation 1999; 100: 587–593. [DOI] [PubMed] [Google Scholar]
- 10. Warkentin TE, Greinacher A. Heparin‐induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311S–337S. [DOI] [PubMed] [Google Scholar]